Skip to main content
Caplight Logo









Olympic Ophthalmics, Inc.

Olympic Ophthalmics, Inc.

Private
Issaquah, WashingtonHealthcare & Life Scienceshttps://olympicophthalmics.com/

Company Overview

Olympic Ophthalmics, Inc. is a medical device company that develops neurostimulation therapies for the treatment of dry eye disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine

Business Model

B2B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

dry eye diseaseneurostimulationmedical devicetear productionneuromodulationeye carenon-invasive stimulationophthalmologytelehealthdrug-free treatmentdigital healtheye drops alternativebioelectronic medicinewearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olympic Ophthalmics, Inc. Comparables

Compare Olympic Ophthalmics, Inc. with similar companies based on industry and business-model similarity.

Olympic Ophthalmics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NuSight Medical
78%
MiBo Medical Group
73%
Oyster Point Medical LLC
73%

Olympic Ophthalmics, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Olympic Ophthalmics, Inc. Investors

Notable investors and investment history

Olympic Ophthalmics, Inc. investors
InvestorRounds
BioStar CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 30% MoM, reaching 3.4K.

  • Jan 21, 2026

    Monthly visitors increased 390% MoM.

Olympic Ophthalmics, Inc. Filings

Explore SEC and related filing metadata, where available.

Olympic Ophthalmics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Olympic Ophthalmics, Inc.'s valuation, stock price, and market status.

Is Olympic Ophthalmics, Inc. a public or private company?

Olympic Ophthalmics, Inc. is a private company.

What is the current stock price of Olympic Ophthalmics, Inc.?

Olympic Ophthalmics, Inc. is a private company with no public stock price. Caplight tracks Olympic Ophthalmics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Olympic Ophthalmics, Inc. worth (valuation)?

Valuation information for Olympic Ophthalmics, Inc. is not publicly available.

Can I buy Olympic Ophthalmics, Inc. stock?

Olympic Ophthalmics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Olympic Ophthalmics, Inc.'s last funding round?

Funding round information for Olympic Ophthalmics, Inc. is not publicly available.

Who are the main investors in Olympic Ophthalmics, Inc.?

Key investors in Olympic Ophthalmics, Inc. include BioStar Capital.

Will Olympic Ophthalmics, Inc. IPO soon?

No public IPO plans have been announced for Olympic Ophthalmics, Inc..

How can I track Olympic Ophthalmics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olympic Ophthalmics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIssaquah, Washington
Employee Range1
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?